The DETOUR 2 Clinical Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 202 participants.

Also called NCT03119233

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 202 participants (enrolled count) (from the registry)
Sponsor
  • Endologix Registry lists this organization as the lead sponsor
Registry
  • NCT NCT03119233
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Germany, Latvia (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03119233. Allocation not applicable; no masking; primary purpose treatment. Start 2017-12-13 (actual); primary completion 2021-12-22 (actual). Results posted on 2025-04-02.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The DETOUR 2 Clinical Trial
Condition
Peripheral Arterial Disease
Intervention (Device)
DETOUR System
Lead sponsor
Endologix (class: industry)

Record details

Record id
cardio:ct-nct03119233
Content hash
7e9b230e4f6275536101fd2846632a1d094fc3823cf7e0dd7ac39e8d6df15e82